论文部分内容阅读
目的探讨不同注入肺表面活性物质方法治疗新生儿呼吸窘迫综合征的临床疗效。方法将2008年9月到2010年10月于我院住院治疗的新生儿呼吸窘迫综合征(NRDS)患儿60例,随机分为传统组和改良组,比较两组治疗前后的平均血氧分压-肺泡氧分压(a/APO2)、PH、PO2和PCO2等动脉血气指标,两组机械通气、氧疗及住院时间及两组合并症情况。结果改良组治疗后的a/APO2、PO2及PCO2指标以及其他项均优于传统组。结论改良注入PS治疗NRDS的临床疗效确切,合并症少,值得推广应用。
Objective To investigate the clinical effects of different pulmonary surfactant injection on neonatal respiratory distress syndrome. Methods Sixty children with neonatal respiratory distress syndrome (NRDS) hospitalized in our hospital from September 2008 to October 2010 were randomly divided into the traditional group and the modified group. The mean oxygen saturation Pressure - alveolar oxygen pressure (a / APO2), PH, PO2 and PCO2 and other arterial blood gas indicators, mechanical ventilation, oxygen therapy and hospital stay and complications of the two groups. Results The a / APO2, PO2, PCO2 index and other items in the improved group were better than those in the traditional group. Conclusion Modified injection of PS in the treatment of NRDS has definite curative effect and few comorbidities, so it is worth popularizing and applying.